Marex Group’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$623K Buy
100,100
+8,400
+9% +$49.4K ﹤0.01% 631
2026
Q1
$405K Buy
91,700
+6,499
+8% +$38.4K ﹤0.01% 680
2025
Q4
$456K Buy
85,201
+16,701
+24% +$133K ﹤0.01% 594
2025
Q3
$659K Sell
68,500
-6,500
-9% -$59.9K ﹤0.01% 432
2025
Q2
$552K Sell
75,000
-7,535
-9% -$50.5K ﹤0.01% 363
2025
Q1
$387K Buy
82,535
+5,035
+6% +$25.1K 0.01% 395
2024
Q4
$351K Buy
+77,500
New +$413K 0.01% 420

Other funds holding ASPI

Marex Group's ASPI Position: Q2 2026 in Review

Marex Group increased its ASP Isotopes (ASPI) stake by 9.2% in Q2 2026, buying an estimated $49.4K and bringing the position to 100,100 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #631.

Marex Group first reported a position in ASPI in Q4 2024 and has held it in 7 quarters since. The position peaked at $659K in Q3 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.

  • Marex Group held 100,100 shares of ASP Isotopes worth $623K as of Q2 2026.
  • Marex Group bought 8,400 ASP Isotopes shares in Q2 2026, an estimated $49.4K.
  • ASP Isotopes made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #631 holding.
  • Marex Group first reported a position in ASP Isotopes in Q4 2024 and has held it in 7 quarters since.
  • Marex Group's ASP Isotopes position peaked at $659K in Q3 2025.
  • 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.